Related Experiment Videos
Leakage-Controlled and Survey-Weighted Machine Learning for Neonatal Mortality Risk Prediction Using NFHS-5 Data
Moumita Mukherjee1, Talha Ali Khan2, Raja Hashim Ali2
1Institute of International Health, Charité-Universitätsmedizin, 13353 Berlin, Germany.
Healthcare (Basel, Switzerland)
|July 28, 2026
Summary
This study developed survey-aware machine learning models to predict neonatal mortality risk in India. Histogram Gradient Boosting showed the strongest performance for low-cost screening, though prospective validation is needed.
Area of Science:
- Public Health
- Machine Learning
- Biostatistics
Background:
- Neonatal mortality rates vary significantly across Indian states.
- Existing prediction models struggle with imbalanced data, data leakage, and complex survey designs.
- This research addresses these limitations using advanced machine learning techniques.
Purpose of the Study:
- To develop and evaluate survey-aware machine learning models for neonatal mortality risk prediction.
- To compare the performance of different machine learning algorithms using National Family Health Survey (NFHS-5) data.
- To assess model calibration, generalizability, and state-level transportability.
Main Methods:
- Analysis of NFHS-5 data from 33,338 children in Bihar, Chhattisgarh, and Uttarakhand.
- Application of survey-aware techniques: grouped cross-validation, sampling weights, fold-contained preprocessing, and feature augmentation.
- Comparison of logistic regression, random forest, histogram gradient boosting (HGB), and artificial neural networks, with PR-AUC as the primary metric.
Main Results:
- Histogram Gradient Boosting (HGB) demonstrated the highest predictive performance (ROC-AUC 0.755, PR-AUC 0.202 on the test set).
- While HGB showed high sensitivity (0.813) and NPV (0.989), PPV was low (0.063).
- Certain methods like clustering and augmentation provided minimal additional value; state-level performance varied.
Conclusions:
- Survey-weighted HGB offers the most robust predictive performance for neonatal mortality risk.
- The model's low positive predictive value and variable state-level results limit its application to preliminary, low-cost screening.
- Further prospective validation is essential before considering deployment in clinical or public health settings.